Innovent Lands $305 Million Investment From Sanofi; Will Partner Two Candidates In China
Sunday, 7 August 2022, 16:53:00
OriCell Therapeutics closed a $120 million Series B financing for its cell therapy and bispecific immunotherapy pipeline.
— Seeking Alpha

Sanofi PT Raised to EUR119 at Stifel
Friday, 5 August 2022, 11:00:01
https://www.investing.com/news/pro/sanofi-pt-raised-to-eur119-at-stifel-432SI-2864714
— Investing.com

Sanofi : Collaboration avec Innovent Biologics en Chine
Friday, 5 August 2022, 09:25:00
Sanofi annonce l”établissement d”une collaboration avec le laboratoire Innovent Biologics, disposant d”une large empreinte en Chine, visant à mettre d – 05/08/2022 07:25
— ABC Bourse

China”s Innovent Biologics secures over $300m investment from Sanofi
Friday, 5 August 2022, 08:23:21
The all-cash investment by the Sanofi unit represents a premium of about 29% to the stock”s last close.
— DealStreetAsia

Diabetes Devices Market Estimated to Experience a Hike in Growth by 2021-2031 | Dexcom, Inc., Johnson & Johnson, Sanofi, Bayer AG
Friday, 5 August 2022, 07:26:46
New York, 2022-Aug-05 — /EPR Network/ — Global Diabetes Devices Market report from Global Insight Services is the single authoritative source of intelligence on Diabetes Devices [read full press release…]
— Express Press Release Distribution
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.